Trivolib Forte 1 Tablet ER

By Trivolib Forte

Rx

15 Tablet ER in a Strip

Composition icon

Composition

Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Pure and Cure Healthcare Private Limited icon

Manufacturer - Pure and Cure Healthcare Private Limited

Sector 8A, I.I.E. , Sidcul Ranipur, Distt., Haridwar 249403 , Uttarakhand

Expires on or after icon

Expires on or after

August, 2027

About Trivolib Forte 1 Tablet ER

Trivolib Forte 1 Tablet ER is a medication used to treat type 2 diabetes in adults. This condition occurs when the body is unable to process glucose properly, leading to increased blood sugar levels. The tablet contains a combination of Glimepiride, Metformin, and Voglibose, which work together to regulate blood sugar levels.

Patients taking Trivolib Forte 1 Tablet ER should ensure they take it with food to avoid stomach upset. It is important to take the medication regularly at the same time each day as prescribed by the doctor. Even if the patient feels well or their blood sugar levels seem controlled, it is crucial to continue taking Trivolib Forte to prevent complications such as kidney damage, blindness, nerve problems, and limb loss.

Common side effects of Trivolib Forte 1 Tablet ER include low blood glucose levels (hypoglycemia), which can result in symptoms like sweating, dizziness, headache, and shaking. To prevent this, it is advised to have regular meals and carry a fast-acting source of glucose, such as sugary food or fruit juice. Avoiding alcohol can also help reduce the risk of low blood sugar levels.

It is essential to consult a doctor before taking Trivolib Forte 1 Tablet ER, especially if the patient has type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart disease. Pregnant or breastfeeding women should also seek medical advice before using this medication. Regular monitoring of blood sugar levels and necessary blood tests are recommended to ensure the medication's effectiveness and safety for the patient.


Benefits

Trivolib Forte 1 Tablet ER offers several benefits in the treatment of Type 2 diabetes mellitus. This medicine plays a crucial role in controlling high blood glucose levels by slowing down the breakdown of food in the intestine, thereby reducing the rise in blood sugar after meals. By helping eliminate excess glucose through urine, it aids in maintaining essential blood glucose levels for diabetes management. Managing blood glucose effectively with Trivolib Forte 1 Tablet ER can lower the risk of serious diabetes-related complications, including kidney damage, eye problems, nerve damage, and even limb loss. Moreover, individuals with type 2 diabetes and existing cardiovascular disease can benefit from decreased cardiovascular mortality risk with regular usage of this medication.


Trivolib Forte 1 Tablet ER , containing Glimepiride, Metformin, and Voglibose, combines the actions of different classes of drugs to offer comprehensive benefits. Glimepiride increases insulin release from the pancreas, Metformin reduces glucose production in the liver and enhances the body's insulin response, while Voglibose inhibits breakdown of complex sugars in the intestine. By preventing blood glucose levels from spiking too high, Trivolib Forte 1 Tablet ER effectively manages diabetes and lowers the risk of complications such as kidney damage, blindness, and nerve problems. Additionally, this combination medication reduces the likelihood of heart attacks or strokes in diabetic individuals.


Choosing Trivolib Forte 1 Tablet ER can streamline medication management as it combines three drugs in a single pill, making it more convenient for individuals to remember and adhere to their treatment regimen. Consistent use of this medication, alongside a proper diet and exercise routine, can significantly contribute to leading a normal and healthy life while safeguarding future health and well-being.


How to use the Trivolib Forte 1 Tablet ER

To use Trivolib Forte 1 Tablet ER effectively, follow the instructions given by your doctor regarding the dosage and duration of use. This medication should be taken on an empty stomach. Swallow the tablet whole with a glass of water, without chewing, crushing, or breaking it. It is important to adhere to these instructions to ensure the proper absorption of the medication into your system. If you have any questions or concerns about how to use Trivolib Forte 1 Tablet ER, consult your doctor or pharmacist for guidance.


Uses of Trivolib Forte 1 Tablet ER

Trivolib Forte 1 Tablet ER is mainly used for treating Type 2 diabetes mellitus. This medication is beneficial for individuals diagnosed with Type 2 diabetes mellitus, a condition that affects the way the body processes blood sugar. By effectively managing blood sugar levels, this tablet helps control diabetes symptoms and reduce the risk of complications associated with the condition. It is important to follow the prescribed dosage and recommendations from healthcare professionals when using Trivolib Forte 1 Tablet ER to achieve the best possible outcomes in managing Type 2 diabetes mellitus.


What conditions Trivolib Forte 1 Tablet ER treats?

Diabetes Mellitus type 2 is a condition where the body may not produce enough insulin or develops resistance to insulin. This can lead to high blood sugar levels. Symptoms include fatigue, increased thirst, blurred vision, and frequent urination. Complications may include skin infections, eye issues, nerve damage, foot ulcers, kidney problems, high blood pressure, and stroke. It's important to manage diabetes properly to prevent these complications.


Should you consult a doctor?

If you experience persistent side effects such as nausea, diarrhea, abdominal pain, hypoglycemia (low blood glucose levels), or loss of appetite while taking Trivolib Forte 1 Tablet ER, it is important to consult your doctor. Additionally, if you notice any signs of low blood glucose levels, such as sweating, dizziness, headache, and shaking, seek medical help promptly. It is crucial to inform your doctor if you have type 1 diabetes mellitus, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart disease before starting this medication. Pregnant or breastfeeding women should also consult their healthcare provider before taking Trivolib Forte 1 Tablet ER. Regular monitoring of blood sugar levels and recommended blood tests as advised by your doctor are essential. Remember, your doctor is the best person to guide you on managing any concerns or potential risks associated with this medication.


Side effects of Trivolib Forte 1 Tablet ER

Common side effects of Trivolib Forte 1 Tablet ER are usually mild and tend to go away as your body gets used to the medication. These side effects may include nausea, diarrhea, stomach pain, and a loss of appetite. In some cases, hypoglycemia, which is a low blood glucose level, may occur. Additionally, you may experience changes in taste, flatulence, headaches, and upper respiratory symptoms while taking this medication. If any of these side effects persist or if you are concerned about them, it is essential to consult your doctor for proper guidance and advice.


Safety advice

scroll

liver

When it comes to using Trivolib Forte 1 Tablet ER, it is important to exercise caution if you have liver disease. Patients with liver conditions may require a dose adjustment when taking this medication. It is advised to consult with your doctor before starting Trivolib Forte 1 Tablet ER. Typically, in individuals with mild to moderate liver disease, the medication is initiated at a low dose. However, for those with severe liver disease, the use of Trivolib Forte 1 Tablet ER is not recommended.

scroll

kidney

Trivolib Forte 1 Tablet ER may not be safe for patients with kidney disease and is not recommended for those with severe kidney issues. Consult your doctor before using.

scroll

alcohol

It is not recommended to drink alcohol while taking Trivolib Forte 1 Tablet ER.

scroll

driving

Driving while taking Trivolib Forte 1 Tablet ER may be risky if you experience low or high blood sugar. It is advised not to drive if such symptoms arise.

scroll

pregnancy

Trivolib Forte 1 Tablet ER may not be safe to use during pregnancy. Animal studies suggest harmful effects on the developing baby. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor.

scroll

breastfeeding

Caution is advised when breastfeeding while using Trivolib Forte 1 Tablet ER as it may be unsafe. Limited data shows the drug can pass into breastmilk and potentially harm the baby.


Consumption warning before consuming Trivolib Forte 1 Tablet ER

Before taking Trivolib Forte 1 Tablet ER, it is important to be aware of some potential risks. Some diabetic patients may develop a rare but serious condition called lactic acidosis when using this medication. Lactic acidosis occurs when there is too much lactic acid in the blood, requiring proper liver and kidney function to eliminate the excess acid. It is vital not to take Trivolib Forte 1 Tablet ER if you have kidney disease, as indicated by a blood test. Additionally, this medication can lower levels of vitamin B12, necessitating annual blood tests to monitor levels. When taken with or without insulin, Trivolib Forte 1 Tablet ER may significantly reduce blood sugar levels, potentially leading to a dosage adjustment of insulin by your doctor. Furthermore, this medication may lower thyroid-stimulating hormone (TSH) levels, making it advisable to undergo an annual TSH check-up.


What if you forgot to take Trivolib Forte 1 Tablet ER?

If you forget to take your Trivolib Forte 1 Tablet ER, take it when you remember. But if it's close to your next dose, just skip the missed one. Don't take extra to make up for it. Just continue with your normal dosing schedule.


Related lab tests

For people taking Trivolib Forte 1 Tablet ER, there are some important lab tests that may be recommended by healthcare providers to monitor the response to the medication and overall health. These tests include:


1. Glucose - Fasting Blood: This test measures the sugar level in the blood after fasting for at least 8 hours. It helps to assess how well the body is able to regulate sugar levels and can indicate if there are any issues with insulin resistance or diabetes management.


2. Glucose - Postprandial Blood: This test measures the sugar level in the blood 2 hours after consuming a meal. It provides information on how the body processes sugar after eating and can help in understanding post-meal glucose control.


3. Glycosylated Hemoglobin: Also known as HbA1c, this test reflects the average blood sugar levels over the past 2-3 months. It is a valuable tool in monitoring long-term glucose control and is often used in the management of diabetes.


Regular monitoring of these lab tests can provide valuable insights into how well the medication is working and help in managing diabetes effectively. Remember to follow your healthcare provider's advice on when and how often to undergo these tests.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

228

Inclusive of all taxes

Content verified by

chevron-right

Dr. Preeti Kumar

MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology

Last update on 01-Oct-2024